Vicore Pharma Holding AB
556680-3804ActiveDeveloping novel ATRAG drugs for severe respiratory diseases.
Overview
- 5–9
- Employees
- 100–500M SEK
- Revenue
- 2005
- Founded
Description
Vicore is an innovative, clinical-stage pharmaceutical company focused on developing life-changing treatments for severe diseases where the AT2 receptor plays a central role. Their primary ambition is unlocking the potential of Angiotensin II Type 2 Receptor Agonists (ATRAGs), a new class of drugs w...
Tags
Keywords
Company Information
- Industry
- Verksamheter som utövas av huvudkontor
- Legal Form
- Aktiebolag
- VAT Number
- SE556680380401
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in Funnelfeedr
CALLUNA PHARMA AS
10 employeesClinical stage biotech pioneering antibodies for inflammation and fibrosis.
Melius Pharma AB
0 employeesSwedish clinical-stage pharma developing low-risk IPF cough treatment.
DiaBridge AB
0 employeesDeveloping breakthrough drugs targeting DNA repair for cancer and inflammation.
Cereno Scientific AB
10–19 employeesPioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
Cinclus Pharma Holding AB (publ)
20–49 employeesSwedish clinical-stage pharma developing superior GERD treatment drug candidate.
Browse More
Vicore Pharma Holding AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo